Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
Joe Y. Chang, Reza J. Mehran, Lei Feng, Vivek Verma, Zhongxing Liao, James W. Welsh, Steven H. Lin, Michael S. O’Reilly, Melenda Jeter, Peter Balter, Stephen E. McRae, Donald A. Berry, John V. Heymach, Jack A. Roth, Mara B. Antonoff, Wayne Hofstetter, Ravi Rajaram, David C. Rice, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh, Craig DeGraaf, Arlene M. Correa, Aileen B. Chen, Saumil Gandhi, Ritsuko Komaki, Percy Lee, Quynh‐Nhu Nguyen, Matthew S. Ning, Song Gao, Julianne Pollard‐Larkin, P Nitsch, R Sadagopan, Xiaochun Wang
Topics & Concepts
MedicineSABR volatility modelRadiation therapySurgeryLung cancerClinical endpointStage (stratigraphy)Propensity score matchingRandomized controlled trialDissection (medical)Internal medicineBiologyFinancial economicsPaleontologyVolatility (finance)Stochastic volatilityEconomicsLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisAdvanced Radiotherapy Techniques